VANCOUVER, British Columbia — January 14, 2026 — Leads & Copy — Avricore Health Inc. (TSXV: AVCR) has announced the planned expansion of its HealthTab™ platform across North East London (NEL), deploying it to an additional 70 community pharmacy sites. This builds on the success of its NHS-linked cardiovascular programmes, delivered in collaboration with Barts Health NHS Trust.
The program has garnered national attention, including coverage by BBC News, highlighting the increasing role of community pharmacies in delivering cardiovascular care. The additional sites are expected to be deployed in the coming weeks. This reflects strong pharmacy engagement, increasing clinical demand, and alignment with NHS priorities to shift more care from hospital settings into the community.
Rodger Seccombe, CEO of Avricore Health, stated that this program is setting a new standard for delivering point-of-care testing effectively and responsibly through community pharmacies, while meeting the clinical and governance expectations of the NHS.
The planned deployment reinforces Avricore’s strategic focus on the UK and demonstrates the scalability of HealthTab™ within complex NHS environments. As pharmacy services continue to expand nationally, HealthTab™ is positioned for further growth across England in both preventive and treatment-linked care pathways.
HealthTab™ is a turnkey solution for community-based POCT networks, combining instruments, cloud software, standardized workflows, and training and support. The core is a secure, cloud-based platform that connects point-of-care analyzers, patient results, and QC data into a unified digital infrastructure for distributed testing environments.
This approach ensures quality-assured testing, consistent data capture across all locations, and real-time analytics for public-health reporting and performance monitoring, while reducing implementation complexity for participating sites.
HealthTab™ is designed to meet analytical performance and reliability standards. Through its partnership with CEQAL Inc., HealthTab operates a quality management program that mirrors accredited clinical laboratories. The program includes centralized lot monitoring of reagents, internal quality-control procedures, regular external quality-assessment (EQA) events, and expert oversight services to support the accuracy, consistency, and traceability of results to internationally recognized reference standards across participating sites.
Avricore Health Inc. (TSXV: AVCR) is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. Through its HealthTab™ offering, the Company’s mission is to make actionable health information more accessible by creating a network of rapid testing devices in community pharmacies.
Contact:
Avricore Health Inc.
info@avricorehealth.com
Source: Avricore Health Inc.
